It has been recently shown that upregulation of A-kinase anchoring protein 1 (Akap1) may have the potential to treat myocardial injury in patients with DCM, where Akap1 expression is reduced in a diabetic mouse heart model. Here, AKAP1 is linked to familial dilated cardiomyopathy.